RBC Capital Sticks to Its Hold Rating for Pro Medicus Limited (PMCUF)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 04 2025
0mins
Source: Business Insider
Analyst Ratings: Garry Sherriff from RBC Capital maintains a Hold rating on Pro Medicus Limited (PMCUF) with a price target of A$220.00, while the average analyst consensus suggests a Moderate Buy rating with a $172.94 price target, indicating a potential upside of 64.70%.
Company Performance: Pro Medicus reported quarterly revenue of $97.19 million and a net profit of $51.75 million, showing significant growth compared to last year's revenue of $74.11 million and net profit of $36.25 million, alongside positive insider sentiment with increased share purchases.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
